tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BNXTF Stock Latest News

BioNxt Solutions Accelerates U.S. Patent for MS Drug and Secures Broad Platform IP
Company AnnouncementsBioNxt Solutions Accelerates U.S. Patent for MS Drug and Secures Broad Platform IP
5d ago
BioNxt Solutions Boosts Investor Relations with Strategic Engagements in Germany
PremiumCompany Announcements
BioNxt Solutions Boosts Investor Relations with Strategic Engagements in Germany
5d ago
BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering
PremiumCompany Announcements
BioNxt Solutions Completes Oversubscribed Convertible Debenture Offering
21d ago
BioNxt Solutions Secures Pending Patent Grants for MS Treatment in Europe and Eurasia
PremiumCompany Announcements
BioNxt Solutions Secures Pending Patent Grants for MS Treatment in Europe and Eurasia
25d ago
BioNxt Solutions Closes First Tranche of Convertible Debenture Private Placement
PremiumCompany Announcements
BioNxt Solutions Closes First Tranche of Convertible Debenture Private Placement
1M ago
BioNxt Achieves Key Milestone with Cladribine Thin-Film Prototype for MS Treatment
PremiumCompany AnnouncementsBioNxt Achieves Key Milestone with Cladribine Thin-Film Prototype for MS Treatment
1M ago
BioNxt Solutions Launches $1.2M Convertible Debenture Offering
Premium
Company Announcements
BioNxt Solutions Launches $1.2M Convertible Debenture Offering
2M ago
BioNxt Solutions Resumes Trading as Cease Trade Order Revoked
Premium
Company Announcements
BioNxt Solutions Resumes Trading as Cease Trade Order Revoked
2M ago
BioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin Film
PremiumCompany Announcements
BioNxt Solutions Launches Feasibility Study for Semaglutide Oral Thin Film
2M ago
BioNxt Solutions Addresses MCTO Status Amid Filing Delays
PremiumCompany Announcements
BioNxt Solutions Addresses MCTO Status Amid Filing Delays
3M ago
BioNxt Solutions Receives Management Cease Trade Order Amidst Filing Delays
PremiumCompany Announcements
BioNxt Solutions Receives Management Cease Trade Order Amidst Filing Delays
3M ago
BioNxt Solutions Secures Key European Patent for Sublingual Drug Delivery
PremiumCompany Announcements
BioNxt Solutions Secures Key European Patent for Sublingual Drug Delivery
3M ago
BioNxt Solutions Provides Update on Management Cease Trade Order
PremiumCompany AnnouncementsBioNxt Solutions Provides Update on Management Cease Trade Order
4M ago
BioNxt Expands R&D Capabilities with Munich Lab Integration
Premium
Company Announcements
BioNxt Expands R&D Capabilities with Munich Lab Integration
4M ago
BioNxt Solutions Secures Eurasian Patent for Sublingual Drug Delivery
Premium
Company Announcements
BioNxt Solutions Secures Eurasian Patent for Sublingual Drug Delivery
4M ago
BioNxt Solutions Delays 2024 Financial Statement Filing
PremiumCompany Announcements
BioNxt Solutions Delays 2024 Financial Statement Filing
4M ago
BioNxt Solutions Advances Human Bioequivalence Study for MS Treatment
PremiumCompany Announcements
BioNxt Solutions Advances Human Bioequivalence Study for MS Treatment
4M ago
BioNxt Solutions Completes $2.5 Million Convertible Debenture Offering
PremiumCompany Announcements
BioNxt Solutions Completes $2.5 Million Convertible Debenture Offering
6M ago
BioNxt Solutions Secures $2.5 Million Through Convertible Debenture Offering
PremiumCompany Announcements
BioNxt Solutions Secures $2.5 Million Through Convertible Debenture Offering
6M ago
BioNxt Solutions Secures $1.6 Million in Convertible Debenture Placement
PremiumCompany AnnouncementsBioNxt Solutions Secures $1.6 Million in Convertible Debenture Placement
6M ago
BioNxt Solutions Sets Strategic 90-Day Plan with Patent, Clinical, and Market Expansions
Premium
Company Announcements
BioNxt Solutions Sets Strategic 90-Day Plan with Patent, Clinical, and Market Expansions
6M ago
BioNxt Solutions Strengthens Board and Amends Warrants
Premium
Company Announcements
BioNxt Solutions Strengthens Board and Amends Warrants
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >